Memorial Sloan-Kettering Cancer Center

Type: Organization
Name: Memorial Sloan-Kettering Cancer Center
First reported 22 hours ago - Updated 8 hours ago - 3 reports

IBM’s Watson Moves From Jeopardy to Cancer Treatment

After delivering a proper thumping to Jeopardy champions Ken Jennings and Brad Rutter, International Business Machines Corp. (NYSE:IBM)’s Watson impressed the world while proving itwasn’t infallible. While racking up points and showing its superiority, ... [Published Value Walk - 20 hours ago]
Entities: IBM Corp, Cancer, Mark Kris
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Cancer Genetics to Participate in ASCO Annual Meeting

Cancer Genetics, Inc. ("CGI" or the "Company"), a provider of oncology-focused personalized medicine, will attend for the first time the 2013 American Society of Clinical Oncology ("ASCO") Annual Meeting on May 31-June 4 at McCormick Place in Chicago. ... [Published Individual.com - 11 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

From the School: Troupe dedicates musical in memory of manager

Grosse Ile High Schools Thespian Troupe 2860 performed the Rodgers and Hammerstein classic Cinderella for its annual spring musical, held April 18 to 20.The troupe was astounding on stage, but their moving efforts during the intermissions deserve applause ... [Published Heritage News-Herald - 17 hours ago]
First reported 20 hours ago - Updated 20 hours ago - 1 reports

UNC’s Rimer gets cancer society award

The American Cancer Society has awarded a Medal of Honor to Dr. Barbara K. Rimer, dean and alumni distinguished professor of Health Behavior at the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill, and a member ... [Published Durham Herald-Sun - 20 hours ago]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Smart way to use PSA to predict prostate cancer risk

Researchers from the Memorial Sloan-Kettering Cancer Centre in the US have developed a new way of using prostate-specific antigen tests to prevent deaths from prostate cancer. The researchers said men who were blood tested at around 45 years of age could ... [Published Individual.com - May 22 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Waiting for a Miracle

People with advanced cancer tend to get more aggressive care at the end of life and spend more time in the intensive care unit if they receive spiritual support from their religious communities, according to a new study.The report’s lead researcher said ... [Published Pacific Standard - May 21 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

'Perspectives on Women and Cancer: An Afternoon Tea' will be held June 2 in Berkeley Heights

This event brings together a panel of experts in an informal setting. Participants will have an opportunity to ask questions, have a conversation, and enjoy light refreshments.Join a distinguished panel of experts, including: Dr. Jiyon Lee, breast imaging ... [Published Independent Press - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

Royalty Pharma Raises Elan Bid to $12.50 a Shae in Cash

Royalty Pharma, an investor in royalty streams from pharmaceuticals, raised its offer to buy Elan Corp. (ELN) after the Irish drugmaker announced several acquisitions to boost revenue and resist the bid.The bid of $12.50 per American depositary receipt ... [Published Bloomberg - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 2 reports

Exelixis to Present at American Society of Clinical Oncology Annual Meeting

Exelixis, Inc. announced its slate of activities in conjunction with the 2013 American Society of Clinical Oncology Annual Meeting, which will be held May 31-June 4, in Chicago. In a release, the company noted that clinical data from cabozantinib will ... [Published Individual.com - May 20 2013]
First reported May 16 2013 - Updated May 17 2013 - 2 reports

Two drugs help shrink Melanoma

There is promising information out about treating advanced Melanoma, which is the deadliest form of skin cancer.New research from Memorial Sloan-Kettering Cancer Center finds a combination of two drugs can shrink Melanoma tumors significantly.The drugs ... [Published KSBY - TV - May 16 2013]
First reported May 16 2013 - Updated May 17 2013 - 2 reports

Researchers use new analysis method to determine genes that result in cell death

Lethal and rescuer genes are defined as genes that when inactivated result in cell death or enhanced cell growth, respectively. The ability to identify these genes in large-scale automated screening campaigns could lead to the discovery of valuable new ... [Published News-Medical.Net - May 17 2013]
First reported May 17 2013 - Updated May 17 2013 - 2 reports

Edward J. Meyer, longtime executive

Edward J. Meyer, 75, an executive who once hawked toothpaste for Bristol-Myers and went on to manage how Sun Refining Co. marketed gasoline and A-Plus mini-marts, died Tuesday, May 14, of complications from cancer.A resident of Bryn Mawr and later Center ... [Published Individual.com - May 17 2013]

Quotes

...every treatment at every patient, we could make intelligent decisions and say, "this is a therapy that has a high probability of success" and "this is a therapy that for all practical purposes will not be useful" and make treatment decisions on that basis...
"Get ValueWalk's Daily Edition By Email and Never Miss Our Top Stories"
Sponsored by: "Because this form of cancer treatment has only recently become known outside of the research world, many people are either unaware of cancer immunotherapy or do not know of its promise in offering safer and more effective treatment" said Jill O'Donnell-Tormey, CEO and director of scientific affairs at the Cancer Research Institute...
...F A C PC P CC P E , Chief Innovations Officer, Professor, and Vice President of Cancer Services and President of Regional Cancer Care Associates, "John Theurer Cancer Center is committed to providing these conferences to improve patient care and education." This conference is free but registration is required. Registration and the complete agenda is available at jtcancercenter...

More Content

All (469) | News (394) | Reports (4) | Blogs (37) | Audio/Video (1) | Fact Sheets (1) | Press Releases (32)
sort by: Date | Relevance
10 drugs that cost more than a car [Published MSN Money - 5 mins ago]
Ten IT-enabled business trends for the decade a... [Published McKinsey & Company - 12 mins ago]
Breast-Conserving Therapy Comparable to Mastect... [Published CancerConnect.com - 1 hour ago]
Jefferies Appoints Gilles Pélisson to Its Globa... [Published Jefferies - 9 hours ago]
Cancer Genetics to Participate in ASCO Annual M... [Published Individual.com - 11 hours ago]
A final test for college grads: Get a job [Published Rochester Democrat and Chronicle - 12 hours ago]
ASCO13: What ‘Building Bridges’ Means for Oncology [Published Oncology Times - 17 hours ago]
From the School: Troupe dedicates musical in me... [Published Heritage News-Herald - 17 hours ago]
Medical school graduate goes from Hampshire to ... [Published Elgin Courier News - 18 hours ago]
Colorectal Cancer Treatments and Therapy Innova... [Published Cancernetwork.com - 18 hours ago]
IBM’s Watson Moves From Jeopardy to Cancer Trea... [Published Value Walk - 20 hours ago]
UNC’s Rimer gets cancer society award [Published Durham Herald-Sun - 20 hours ago]
IBM’s Watson Moving Closer to Patient Care [Published NBR.com - 21 hours ago]
Big Data Downsize: Improving Watson [Published NBR.com - 21 hours ago]
Phelps Memorial Hospital Center Establishes The... [Published PRWeb - 21 hours ago]
Cancer Research Institute Hosting Free Cancer I... [Published TickerTech.com - 21 hours ago]
Progress after recent breakthrough which opened... [Published EurekAlert! - 22 hours ago]
IBM's Watson Is Being Taught to Treat Cancer [Published CNBC - 22 hours ago]
Marcia Cross Stars In New PSA About Prostate Ca... [Published Individual.com - May 22 2013]
Luke Johnson: The madness of investing in boomi... [Published Management Today Magazine - May 22 2013]
Manchester Uni appoints world-leading academic ... [Published Student Times - May 22 2013]
Smart way to use PSA to predict prostate cancer... [Published Individual.com - May 22 2013]
IBM's Watson Is Bringing "Cognitive Computing" ... [Published Popular Science - May 21 2013]
IBM's Watson Is Bringing "Cognitive Computing" ... [Published Popular Science - New Technology, Science News, ... - May 21 2013]
IBM’s Watson: The Consumer Answer? [Published NBR.com - May 21 2013]
Waiting for a Miracle [Published Pacific Standard - May 21 2013]
PERCIST: PET Interpretation Improved [Published MolecularImaging.net - May 21 2013]
A molecular explanation for age-related fertili... [Published WebWire - May 21 2013]
IBM's Watson: The Consumer Answer? [Published CNBC - May 21 2013]
Sound Shore Chief of Molecular Genetics Speaker... [Published Hospital Newspaper - May 21 2013]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
How Drug Companies Keep Medicine Out of Reach -... [Published PharmaGossip - May 15 2013]
http://www.theatlantic.com/health/archive/2013/05/how-drug-companies-keep-medicine-out-of-reach/275853/? Reuters For almost a decade, the United States has been standing in the way of an idea that could lead to cures for some of the world's most devastating ...
Genomics to reshape endometrial cancer treatment [Published WUSTL Medicine & Healthcare News - May 01 2013]
Robert Boston Scientists at Washington University's Genome Institute have shown that adding genomics-based testing to the standard diagnostic workup for endometrial cancer could change the recommended treatment for some women. The most in-depth look ...
Ethics of $100,000 cancer drugs [Published AdBanks.net - Apr 28 2013]
An annual supply of Glivec (sold in the U.S. as Gleevec) wholesales for $76,740, much more than it cost a decade ago. Should a life-saving drug that can be profitably sold for far less cost more than $100,000 per year? A group of more than 120 ...
Deals Of The Week Ponders Project Financing [Published The IN VIVO Blog - Apr 26 2013]
GlaxoSmithKline has been out ahead of other big pharmas when it comes to investing in venture funds. Its deal with Avalon Ventures represents another flavor of the relationship – investing as a partner rather than as an LP and creating companies around ...
Doctors Denounce Cancer Drug Prices of $100,000... [Published PharmaGossip - Apr 26 2013]
With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual step of banding together in hopes of persuading some leading pharmaceutical companies to ...
1 2 3 4 5 6 7 8

Audio/Video

sort by: Date | Relevance
Show Me the Money: Reimbursement in an ACA World [Published BIO Channel - YouTube - Feb 26 2013]
1

Press Releases

sort by: Date | Relevance
Cancer Genetics to Attend ASCO Annual Meeting [Published Business Wire - May 20 2013]
Reminder: Cabozantinib to be Featured in Nine P... [Published Business Wire - May 15 2013]
Apricus Biosciences Announces Poster Presentati... [Published GlobeNewswire: Acquisitions News - May 07 2013]
Foundation Medicine and Memorial Sloan-Ketterin... [Published Business Wire - May 02 2013]
Foundation Medicine and Memorial Sloan-Ketterin... [Published Business Wire Health News - May 02 2013]
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.